Nutrition in multiple sclerosis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Farinotti, 2007, Dietary interventions for multiple sclerosis, Cochrane Database Syst Rev, 24, 10.1002/14651858.CD004192.pub2
Schwartz, 1999, Utilization of unconventional treatments by persons with MS: is it alternative or complementary?, Neurology, 52, 626, 10.1212/WNL.52.3.626
Payne, 2001, Nutrition and diet in the clinical management of multiple sclerosis, J Hum Nutr Diet, 14, 349, 10.1046/j.1365-277X.2001.00308.x
Das, 2003, Is there a role for saturated and long-chain fatty acids in multiple sclerosis?, Nutrition, 19, 163, 10.1016/S0899-9007(02)00923-1
Swank, 2003, How saturated fats may be a causative factor in multiple sclerosis and other diseases, Nutrition, 19, 478, 10.1016/S0899-9007(02)01099-7
Antonovsky, 1965, Epidemiologic study of multiple sclerosis in Israel. I. An overall review of methods and findings, Arch Neurol, 13, 183, 10.1001/archneur.1965.00470020073010
Cendrowski, 1969, Epidemiological study of multiple sclerosis in western Poland, Eur Neurol, 2, 90, 10.1159/000113777
Berr, 1989, Risk factors in multiple sclerosis: a population-based case–control study in Hautes-Pyrenees, France, Acta Neurol Scand, 80, 46, 10.1111/j.1600-0404.1989.tb03841.x
Tola, 1994, Dietary habits and multiple sclerosis. A retrospective study in Ferrara, Italy, Acta Neurol (Napoli), 16, 189
Zhang, 2000, Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women, Am J Epidemiol, 152, 1056, 10.1093/aje/152.11.1056
Sepcic, 1993, Nutritional factors and multiple sclerosis in Gorski Kota, Croatia, Neuroepidemiology, 12, 234, 10.1159/000110322
Isaacs, 2010, Impact of breast milk on IQ, brain size and white matter development, Pediatr Res, 67, 357, 10.1203/PDR.0b013e3181d026da
Brown, 2006, The role of vitamin D in multiple sclerosis, Ann Pharmacother, 40, 1158, 10.1345/aph.1G513
Kidd, 2001, Multiple sclerosis, an autoimmune inflammatory disease: prospects for its integrative management, Altern Med Rev, 6, 540
Auer, 2000, Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis, Ann Neurol, 47, 276, 10.1002/1531-8249(200002)47:2<276::AID-ANA28>3.0.CO;2-1
Hayes, 2000, Vitamin, D: a natural inhibitor of multiple sclerosis, Proc Nutr Soc, 59, 531, 10.1017/S0029665100000768
Eyles, 2007, Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain, J Steroid Biochem Mol Biol, 103, 538, 10.1016/j.jsbmb.2006.12.096
Cantorna, 2008, Vitamin D and multiple sclerosis: an update, Nutr Rev, 66, S135, 10.1111/j.1753-4887.2008.00097.x
Munger, 2006, Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis, JAMA, 296, 2832, 10.1001/jama.296.23.2832
Koch, 2006, Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis, J Neurol, 253, 483, 10.1007/s00415-005-0037-3
Ferretti, 2005, Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity, Mult Scler, 11, 677, 10.1191/1352458505ms1240oa
Gilgun-Sherki, 2004, The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy, J Neurol, 251, 261, 10.1007/s00415-004-0348-9
Butcher, 1976, The distribution of multiple sclerosis in relation to the dairy industry and milk consumption, N Z Med J, 83, 427
Ramagopalan, 2010, Childhood cow's milk allergy and the risk of multiple sclerosis: Aa population based study, J Neurol Sci, 291, 86, 10.1016/j.jns.2009.10.021
Shor, 2009, Gluten sensitivity in multiple sclerosis: experimental myth or clinical truth?, Ann NY Acad Sci, 1173, 343, 10.1111/j.1749-6632.2009.04620.x
Reichelt, 2004, IgA antibodies against gliadin and gluten in multiple sclerosis, Acta Neurol Scand, 110, 239, 10.1111/j.1600-0404.2004.00303.x
Borhani Haghighi, 2007, Multiple sclerosis and gluten sensitivity, Clin Neurol Neurosurg, 109, 651, 10.1016/j.clineuro.2007.04.011
Pasquinelli, 2008, Nutritional assessment and malnutrition in multiple sclerosis, Neurol Sci, 29, S367, 10.1007/s10072-008-1046-7
Pennington, 1997, Disease and malnutrition in British hospitals, Proc Nutr Soc, 6, 393, 10.1079/PNS19970041
Kamalian, 1975, Lateral hypothalamic demyelination and cachexia in a case of ‘malignant’ multiple sclerosis, Neurology, 25, 25, 10.1212/WNL.25.1.25
Fantelli, 1978, Multiple sclerosis and malabsorption, Lancet, 1, 1039, 10.1016/S0140-6736(78)90758-4
Williams, 1988, Iron and zinc status in multiple sclerosis patients with pressure sores, Eur J Clin Nutr, 42, 321
Wozniak-Wowk, 1993, Nutrition intervention in the management of multiple sclerosis, Nutr Today, 28, 12, 10.1097/00017285-199311000-00004
Slawta, 2003, Health behaviors, body composition, and coronary heart disease risk in women with multiple sclerosis, Arch Phys Med Rehabil, 84, 1823, 10.1016/S0003-9993(03)00466-0
Timmerman, 1999, Eating patterns in women with multiple sclerosis, Neurosci Nurs, 31, 152, 10.1097/01376517-199906000-00004
Hewson, 1984, Food intake in multiple sclerosis, Hum Nutr Appl Nutr, 38, 355
Khurana, 2009, The prevalence of overweight and obesity in veterans with multiple sclerosis, Am J Phys Med Rehabil, 88, 83, 10.1097/PHM.0b013e318194f8b5
Hunt, 1985, A simple nutrition screening procedure for hospital patients, J Am Diet Assoc, 85, 332, 10.1016/S0002-8223(21)03608-7
Detsky, 1987, What is subjective global assessment of nutritional status?, J Parenter Enteral Nutr, 11, 8, 10.1177/014860718701100108
Rubenstein, 2001, Screening for undernutrition in geriatric practice: developing the short-form mininutritional assessment (MNA-SF), J Gerontol A Biol Sci Med Sci, 56, 366, 10.1093/gerona/56.6.M366
British Association for Enteral and Parenteral Nutrition (BAPEN). The ‘MUST’ explanatory booklet. A guide to ‘Malnutrition Universal Screening Tool’ (‘MUST’) for adults; November 2003. Available at: http://www.bapen.org.uk/pdfs/must/must_explan.pdf) [accessed July 15, 2008].
Kondrup, 2003, European Society for Parenteral and Enteral Nutrition (ESPEN). ESPEN guidelines for nutrition screening 2002, Clin Nutr, 22, 415, 10.1016/S0261-5614(03)00098-0
Correia, 2003, The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis, Nutrition, 22, 235
Carney, 2002, Current concepts in nutritional assessment, Arch Surg, 137, 42, 10.1001/archsurg.137.1.42
Maqbool, 2008, Clinical assessment of nutritional status, 5
Zemel, 1997, Evaluation of methodology for nutritional assessment in children: anthropometry, body composition, and energy expenditure, Annu Rev Nutr, 17, 211, 10.1146/annurev.nutr.17.1.211
DeLegge, 2007, Nutritional assessment, Gastroenterol Clin North Am, 36, 1, 10.1016/j.gtc.2007.02.001
Morgan, 1980, The assessment of weight loss from a single measurement of body weight: problems and limitations, Am J Clin Nutr, 33, 2101, 10.1093/ajcn/33.10.2101
Blackburn, 1977, Nutritional and metabolic assessment of the hospitalized patient, JPEN J Parenter Enteral Nutr, 1, 11, 10.1177/014860717700100111
Carney, 2002, Current concepts in nutritional assessment, Arch Surg, 137, 42, 10.1001/archsurg.137.1.42
Evans-Stoner, 1997, Nutrition assessment: a practical approach, Nurs Clin North Am, 32, 637, 10.1016/S0029-6465(22)02682-2
Bailey J. Healthy eating: a guide for people with MS; 2008 [available at: http://www.mssociety.ca/en/pdf/eating.pdf].
Shinto, 2004, Complementary and alternative medicine in multiple sclerosis: survey of licensed naturopaths, J Altern Complement Med, 10, 891, 10.1089/acm.2004.10.891
Millar, 1973, Double-blind trial of linoleate supplementation of the diet in multiple sclerosis, Br Med J, 1, 765, 10.1136/bmj.1.5856.765
Bates, 1977, Trail of polyunsaturated fatty acids in non-relapsing multiple sclerosis, Br Med J, 2, 932, 10.1136/bmj.2.6092.932-a
Bates, 1978, Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis, Br Med J, 2, 1390, 10.1136/bmj.2.6149.1390
Bates, 1989, A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis, J Neurol Neurosurg Psychiatry, 52, 18, 10.1136/jnnp.52.1.18
Weinstock-Guttman, 2005, Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients, Prostaglandins Leukot Essent Fatty Acids, 73, 397, 10.1016/j.plefa.2005.05.024
Cantorna, 1996, 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis, Proc Natl Acad Sci USA, 93, 7861, 10.1073/pnas.93.15.7861
Spach, 2004, Gene expression analysis suggests that 1,25- dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis, Physiol Genomics, 18, 141, 10.1152/physiolgenomics.00003.2004
Goldberg, 1986, Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D, Med Hypotheses, 21, 193, 10.1016/0306-9877(86)90010-1
Wingerchuk, 2005, A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis, J Neurol Neurosurg Psychiatry, 76, 1294, 10.1136/jnnp.2004.056499
Wade, 2002, A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and l-phenylalanine (the “Cari Loder regime”) in the treatment of multiple sclerosis, J Neurol Neurosurg Psychiatry, 73, 246, 10.1136/jnnp.73.3.246